Erratum to: Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120

被引：0
|
作者：
James M Binley
Stacie Ngo-Abdalla
Penny Moore
Michael Bobardt
Udayan Chatterji
Philippe Gallay
Dennis R Burton
Ian A Wilson
John H Elder
Aymeric de Parseval
机构：
[1] Torrey Pines Institute for Molecular Studies,Department of Molecular Biology
[2] The Scripps Research Institute,Department of Immunology
[3] National Institute for Communicable Diseases,Department of Immunology and Molecular Biology
[4] The Scripps Research Institute,Department of Molecular Biology and The Skaggs Institute for Chemical Biology
[5] The Scripps Research Institute,undefined
[6] The Scripps Research Institute,undefined
来源：
Retrovirology | / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 31 条
  • [21] Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: Implications for structural analyses of gp120-DC-SIGN binding
    Hong, PWP
    Flummerfelt, KB
    de Parseval, A
    Gurney, K
    Elder, JH
    Lee, B
    JOURNAL OF VIROLOGY, 2002, 76 (24) : 12855 - 12865
  • [22] N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization
    Gray, Elin S.
    Moore, Penny L.
    Pantophlet, Ralph A.
    Morris, Lynn
    JOURNAL OF VIROLOGY, 2007, 81 (19) : 10769 - 10776
  • [23] 2G12/PGT-binding yeast glycoprotein Gp38 elicits mannose-specific HIV-1 Env cross-reactive antibodies
    H Zhang
    H Fu
    B Liu
    RJ Luallen
    RW Doms
    DF Smith
    Y Geng
    Retrovirology, 9
  • [24] 2G12/PGT-binding yeast glycoprotein Gp38 elicits mannose-specific HIV-1 Env cross-reactive antibodies
    Zhang, H.
    Fu, H.
    Liu, B.
    Luallen, R. J.
    Doms, R. W.
    Smith, D. F.
    Geng, Y.
    RETROVIROLOGY, 2012, 9
  • [25] The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12
    Chaillon, A.
    Braibant, M.
    Autran, B.
    Barin, F.
    RETROVIROLOGY, 2009, 6
  • [26] A 2-4-Amino Acid Deletion in the V5 Region of HIV-1 Env gp120 Confers Viral Resistance to the Broadly Neutralizing Human Monoclonal Antibody, VRC01
    Tachibana, Shingo
    Sasaki, Maho
    Tanaka, Takako
    Inoue, Mari
    Ophinni, Youdiil
    Kotaki, Tomohiro
    Kameoka, Masanori
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2017, 33 (12) : 1248 - 1257
  • [27] An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies
    Luallen, Robert J.
    Lin, Jianqiao
    Fu, Hu
    Cai, Karen K.
    Agrawal, Caroline
    Mboudjeka, Innocent
    Lee, Fang-Hua
    Montefiori, David
    Smith, David F.
    Doms, Robert W.
    Geng, Yu
    JOURNAL OF VIROLOGY, 2008, 82 (13) : 6447 - 6457
  • [28] P04-17. The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12
    A Chaillon
    M Braibant
    B Autran
    F Barin
    Retrovirology, 6
  • [29] Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies
    Nabatov, AA
    Pollakis, G
    Linnemann, T
    Kliphius, A
    Chalaby, MIM
    Paxton, WA
    JOURNAL OF VIROLOGY, 2004, 78 (01) : 524 - 530
  • [30] Polydeoxyguanine motifs in a 12-mer phosphorothioate oligodeoxynucleotide augment binding to the v3 loop of HIV-1 gp120 and potency of HIV-1 inhibition independently of G-tetrad formation
    Lederman, S
    Sullivan, G
    Benimetskaya, L
    Lowy, I
    Land, K
    Khaled, Z
    Cleary, AM
    Yakubov, L
    Stein, CA
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1996, 6 (04): : 281 - 289
1234